Identifying non‐responders to treatments for myopia

Ophthalmic and Physiological OpticsEarly View GUEST EDITORIAL Identifying non-responders to treatments for myopia Jeremy A. Guggenheim, Corresponding Author Jeremy A. Guggenheim [email protected] orcid.org/0000-0001-5164-340X School of Optometry & Vision Sciences, Cardiff University, Cardiff, UK Correspondence Jeremy A. Guggenheim, School of Optometry & Vision Sciences, Cardiff University, Cardiff, UK. Email: [email protected]Search for more papers by this authorJeffrey J. Walline, Jeffrey J. Walline orcid.org/0000-0002-9503-6094 The Ohio State University College of Optometry, Columbus, Ohio, USASearch for more papers by this author Jeremy A. Guggenheim, Corresponding Author Jeremy A. Guggenheim [email protected] orcid.org/0000-0001-5164-340X School of Optometry & Vision Sciences, Cardiff University, Cardiff, UK Correspondence Jeremy A. Guggenheim, School of Optometry & Vision Sciences, Cardiff University, Cardiff, UK. Email: [email protected]Search for more papers by this authorJeffrey J. Walline, Jeffrey J. Walline orcid.org/0000-0002-9503-6094 The Ohio State University College of Optometry, Columbus, Ohio, USASearch for more papers by this author First published: 10 May 2023 https://doi.org/10.1111/opo.13162Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1Sacchi M, Serafino M, Villani E, Tagliabue E, Luccarelli S, Bonsignore F, et al. Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients. Acta Ophthalmol. 2019; 97: e1136– 40. 2Prieto-Garrido FL, Hernández Verdejo JL, Villa-Collar C, Ruiz-Pomeda A. Predicting factors for progression of the myopia in the MiSight assessment study Spain (MASS). J Optom. 2021; 15: 78– 87. 3Moriche-Carretero M, Revilla-Amores R, Diaz-Valle D, Morales-Fernández L, Gomez-de-Liaño R. Myopia progression and axial elongation in Spanish children: efficacy of atropine 0.01% eye-drops. J Fr Ophtalmol. 2021; 44: 1499– 504. 4Prieto-Garrido FL, Villa-Collar C, Hernandez-Verdejo JL, Alvarez-Peregrina C, Ruiz-Pomeda A. Changes in the choroidal thickness of children wearing MiSight to control myopia. J Clin Med. 2022; 11:3833. https://doi.org/10.3390/jcm11133833 5Lee LC, Hsieh MW, Chen YH, Chen PL, Chien KH. Characteristics of responders to atropine 0.01% as treatment in Asian myopic children. Sci Rep. 2022; 12:7380. https://doi.org/10.1038/s41598-022-10978-3 6Donovan L, Sankaridurg P, Ho A, Chen X, Lin Z, Thomas V, et al. Myopia progression in Chinese children is slower in summer than in winter. Optom Vis Sci. 2012; 89: 1196– 202. 7Fulk GW, Cyert LA, Parker DA. Seasonal variation in myopia progression and ocular elongation. Optom Vis Sci. 2002; 79: 46– 51. 8Gwiazda JE, Deng L, Manny RE, Norton TT. Seasonal variations in the progression of myopia in children enrolled in the correction of myopia evaluation trial. Invest Ophthalmol Vis Sci. 2014; 55: 752– 8. 9Mutti DO, Sinnott LT, Brennan NA, Cheng X, Zadnik K. The limited value of prior change in predicting future progression of juvenile-onset myopia. Optom Vis Sci. 2022; 99: 424– 33. 10Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023; 2:Cd014758. https://doi.org/10.1002/14651858.CD014758.pub2 11Weng R, Lan W, Bakaraju R, Conrad F, Naduvilath T, Yang ZK, et al. Efficacy of contact lenses for myopia control: insights from a randomised, contralateral study design. Ophthalmic Physiol Opt. 2022; 42: 1253– 63. 12Senn S. Individual response to treatment: is it a valid assumption? BMJ. 2004; 329: 966– 8. 13Senn S. Mastering variation: variance components and personalised medicine. Stat Med. 2016; 35: 966– 77. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation